04/19/2024 6:55 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
04/19/2024 6:36 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
04/19/2024 6:44 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
04/08/2024 4:08 PM | Karyopharm Therapeutics (Subject)
| Form SC TO-C | |
04/08/2024 3:40 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
04/05/2024 4:20 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:36 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/04/2024 6:37 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:38 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:39 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:40 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:41 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:34 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:36 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:43 AM | Karyopharm Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 6:35 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 9:33 AM | Avidity Partners Management LP (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024 5:06 AM | Karyopharm Therapeutics (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
02/08/2024 3:36 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:40 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:43 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:47 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:53 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:14 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:16 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 12:50 PM | Karyopharm Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/08/2024 8:00 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 7:40 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 4:03 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 4:32 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 6:57 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 6:37 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 3:46 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 3:07 PM | BOHLIN GAREN G (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
A new way to collect income from stocks (Ad) Most people think of BUYING options when they talk about options.
It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
The problem is - they don’t always pay off when you buy them.
In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. |
09/05/2023 3:27 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:29 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 7:06 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/01/2023 7:17 AM | Karyopharm Therapeutics (Issuer) Su Zhen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/01/2023 7:20 AM | Karyopharm Therapeutics (Issuer) Su Zhen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/02/2023 7:59 AM | Karyopharm Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/02/2023 6:48 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023 6:37 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2023 4:37 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2023 1:26 PM | Karyopharm Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
07/06/2023 4:36 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2023 11:15 PM | Karyopharm Therapeutics (Filer)
| Form EFFECT | |
05/04/2023 6:53 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 7:04 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2023 5:09 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |